We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.9B
AUM Growth
+$1.55B
(+10%)
Cap. Flow
+$560M
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
18.6%
Holding
1,263
New
50
Increased
577
Reduced
391
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$57.5M |
| 2 |
Emerson Electric
EMR
|
+$45M |
| 3 |
Johnson & Johnson
JNJ
|
+$41.1M |
| 4 |
WEC Energy
WEC
|
+$36.5M |
| 5 |
Clorox
CLX
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$63.8M |
| 2 |
Chevron
CVX
|
+$33.9M |
| 3 |
SLB Ltd
SLB
|
+$32.7M |
| 4 |
Lam Research
LRCX
|
+$22.8M |
| 5 |
Merck
MRK
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 16.61% |
| 3 | Financials | 14.79% |
| 4 | Communication Services | 9.7% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Sysco
SYY
$40.3B
| $33.9M | 0.2% |
456,152
-101,564
| -18% | -$7.32M |
|
127
Newell Brands
NWL
$2.56B
| $33.8M | 0.2% |
1,543,693
-350,881
| -19% | -$8.24M |
|
128
PVH
PVH
$4.04B
| $33.4M | 0.2% |
235,473
+171,403
| +268% | +$25.3M |
|
129
Las Vegas Sands
LVS
$29.6B
| $33M | 0.2% |
501,467
-25,113
| -5% | -$1.69M |
|
130
Ross Stores
ROST
$81.9B
| $33M | 0.2% |
346,019
+11,335
| +3% | +$1.04M |
|
131
Viatris
VTRS
$18.9B
| $33M | 0.19% |
836,978
+16,262
| +2% | +$610K |
|
132
Royal Caribbean
RCL
$85.6B
| $32.9M | 0.19% |
267,257
+146,356
| +121% | +$17.2M |
|
133
Xylem
XYL
$28.1B
| $32.3M | 0.19% |
424,819
+20,576
| +5% | +$1.54M |
|
134
Broadcom
AVGO
$2.04T
| $32.3M | 0.19% |
1,469,050
-375,360
| -20% | -$8.42M |
|
135
Republic Services
RSG
$65.7B
| $32.1M | 0.19% |
436,626
-7,344
| -2% | -$532K |
|
136
ConocoPhillips
COP
$141B
| $32M | 0.19% |
430,478
-2,219
| -0.5% | -$160K |
|
137
EOG Resources
EOG
$70.7B
| $31.8M | 0.19% |
265,750
+4,757
| +2% | +$578K |
|
138
CBRE Group
CBRE
$42.9B
| $31.7M | 0.19% |
658,080
+22,458
| +4% | +$1.07M |
|
139
Scotiabank
BNS
$108B
| $31.7M | 0.19% |
544,436
+15,290
| +3% | +$893K |
|
|
CMA
140
DELISTED
Comerica
CMA
| $31.6M | 0.19% |
325,351
-44,287
| -12% | -$4.22M |
|
141
Fortive
FTV
$18.6B
| $31.5M | 0.19% |
594,820
+15,099
| +3% | +$774K |
|
142
Illumina
ILMN
$28.4B
| $31.5M | 0.19% |
91,149
+2,446
| +3% | +$784K |
|
143
S&P Global
SPGI
$120B
| $31M | 0.18% |
149,591
+17,068
| +13% | +$3.52M |
|
144
Eastman Chemical
EMN
$8.42B
| $30.9M | 0.18% |
315,434
+14,139
| +5% | +$1.4M |
|
145
Elevance Health
ELV
$85.5B
| $30.4M | 0.18% |
113,616
+2,493
| +2% | +$647K |
|
146
Cencora
COR
$61.2B
| $30.2M | 0.18% |
334,642
-10,956
| -3% | -$948K |
|
147
NXP Semiconductors
NXPI
$60.4B
| $30M | 0.18% |
324,891
-14,253
| -4% | -$1.37M |
|
148
Bristol-Myers Squibb
BMY
$132B
| $29.7M | 0.18% |
483,720
-34,313
| -7% | -$2.04M |
|
149
Charles River Laboratories
CRL
$12.8B
| $29.4M | 0.17% |
241,596
| – | – |
|
150
Charter Communications
CHTR
$18.2B
| $29M | 0.17% |
92,980
-359
| -0.4% | -$110K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2018 Portfolio in Review
As of Q3 2018, DekaBank Deutsche Girozentrale held 1,263 positions worth $16.9B, up 10% from $15.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
DekaBank Deutsche Girozentrale deployed $560M of net new capital in Q3 2018, opening 50 new positions and adding to 577 existing holdings. Its largest new stake was Tilray: 8,950 shares worth $5.29M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Praxair Inc, an estimated $63.8M trimmed.
- DekaBank Deutsche Girozentrale's largest Q3 2018 buy was Tilray: 8,950 shares worth $5.29M.
- DekaBank Deutsche Girozentrale added most to Pfizer in Q3 2018, an estimated $57.5M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2018 reduction was Praxair Inc, cutting an estimated $63.8M.
- DekaBank Deutsche Girozentrale fully exited J.C. Penney Company, Inc. in Q3 2018, selling an estimated $3.94M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 19% of its $16.9B portfolio in Q3 2018.
- DekaBank Deutsche Girozentrale opened 50 new positions and closed 38 in Q3 2018.
- DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $16.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2018, filed 9 Nov 2018.